Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

TGF-β2 helps yak hair follicles enter the regression phase, while HSP70 tries to prevent it.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

People with acne have more CD4+ immune cells in their skin than healthy people.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.

TCDD changes skin cell growth and keratin production in mice.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

Serotonin helps wounds heal faster.

Immune cells might contribute to hair loss caused by a specific mutation.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.